Skip to main content
TipRanks
Go Ultimate75% OFF

Altimmune (ALT) Q2 2023 Earnings Report

3,809 Followers

ALT Q2 2023 EPS Results

Actual EPS
-$0.32
Consensus EPS
-$0.47
Beat/Miss
Beat by +$0.15
One Year Ago EPS
-$0.42

ALT Q2 2023 Revenue Results

Actual Revenue
$6,000
Expected Revenue
$3,000
Beat/Miss
Beat by +$3,000
YoY Revenue Growth
-25.00%

Earnings Announcement Details

Quarter
Q2 2023
Date
08/10/2023
Time
Before Open
Conference Call
Thursday, August 10, 2023
ALT Upcoming Earnings

Altimmune's next earnings date is estimated for March 3, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

ALT Q2 2023 Earnings Call
0:00 / 0:00

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

ALT Earnings History

ALT earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 03, 20272026 (Q4)-0.17--0.27――
Nov 12, 20262026 (Q3)-0.13-0.15-0.2128.57% (+0.06)
Aug 12, 20262026 (Q2)-0.14-0.12-0.2755.56% (+0.15)
May 13, 20262026 (Q1)-0.24-0.18-0.2630.77% (+0.08)
Mar 05, 20262025 (Q4)-0.24-0.27-0.3318.18% (+0.06)
Nov 06, 20252025 (Q3)-0.27-0.21-0.3234.38% (+0.11)
Aug 12, 20252025 (Q2)-0.34-0.27-0.3522.86% (+0.08)
May 13, 20252025 (Q1)-0.35-0.26-0.3423.53% (+0.08)
Feb 27, 20252024 (Q4)-0.33-0.33-0.5438.89% (+0.21)
Nov 12, 20242024 (Q3)-0.36-0.32-0.3917.95% (+0.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed